Using advanced imaging to improve breast cancer prognosis
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
This study is exploring a new imaging method to help doctors get a clearer picture of breast cancer from tissue samples, so they can make better treatment choices and improve outcomes for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10703212 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy of breast cancer prognosis through innovative imaging techniques. By utilizing Spatial Light Interference Microscopy (SLIM), the study aims to extract detailed information about tissue morphology that remains consistent despite variations in biopsy preparation. This approach seeks to identify reliable prognostic markers from tissue samples, which can help clinicians make better-informed treatment decisions. The goal is to improve patient outcomes by providing personalized treatment options based on more accurate prognostic assessments.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with invasive breast cancer who are undergoing tissue biopsies for prognostic evaluation.
Not a fit: Patients with non-invasive breast cancer or those who do not require tissue biopsies for their treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate prognostic tools for breast cancer, ultimately improving treatment outcomes for patients.
How similar studies have performed: Preliminary results from similar imaging techniques have shown promise in distinguishing patient outcomes, indicating potential for success in this novel approach.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Anastasio, Mark a — University of Illinois at Urbana-Champaign
- Study coordinator: Anastasio, Mark a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.